These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 35123490)

  • 1. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
    Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
    J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
    Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
    F1000Res; 2023; 12():528. PubMed ID: 37928173
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
    J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort.
    Wang J; Chai J; Sun L; Zhao J; Chang C
    BMC Infect Dis; 2020 Aug; 20(1):610. PubMed ID: 32811432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.
    Leitao Filho FS; Alotaibi NM; Ngan D; Tam S; Yang J; Hollander Z; Chen V; FitzGerald JM; Nislow C; Leung JM; Man SFP; Sin DD
    Am J Respir Crit Care Med; 2019 May; 199(10):1205-1213. PubMed ID: 30376356
    [No Abstract]   [Full Text] [Related]  

  • 7. Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study.
    Xue Q; Xie Y; He Y; Yu Y; Fang G; Yu W; Wu J; Li J; Zhao L; Deng X; Li R; Wang F; Zheng Y; Gao Z
    Sci Rep; 2023 Apr; 13(1):5715. PubMed ID: 37029178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease.
    Su L; Qiao Y; Luo J; Huang R; Xiao Y
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the correlation between BMI and respiratory tract microbiota in acute exacerbation of COPD.
    Cao Y; Chen X; Shu L; Shi L; Wu M; Wang X; Deng K; Wei J; Yan J; Feng G
    Front Cell Infect Microbiol; 2023; 13():1161203. PubMed ID: 37180432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
    Wang Z; Singh R; Miller BE; Tal-Singer R; Van Horn S; Tomsho L; Mackay A; Allinson JP; Webb AJ; Brookes AJ; George LM; Barker B; Kolsum U; Donnelly LE; Belchamber K; Barnes PJ; Singh D; Brightling CE; Donaldson GC; Wedzicha JA; Brown JR;
    Thorax; 2018 Apr; 73(4):331-338. PubMed ID: 29269441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
    Huang YJ; Boushey HA
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD.
    Liu H; Zheng D; Lin Y; Liu Z; Liang Z; Su J; Chen R; Zhou H; Wang Z
    Pharmacol Res; 2020 Oct; 160():105095. PubMed ID: 32730904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sputum microbiome is distinct between COPD and health, independent of smoking history.
    Haldar K; George L; Wang Z; Mistry V; Ramsheh MY; Free RC; John C; Reeve NF; Miller BE; Tal-Singer R; Webb AJ; Brookes AJ; Tobin MD; Singh D; Donaldson GC; Wedzicha JA; Brown JR; Barer MR; Brightling CE
    Respir Res; 2020 Jul; 21(1):183. PubMed ID: 32664956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
    Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saliva as a non-invasive specimen for COPD assessment.
    Melo-Dias S; Valente C; Andrade L; Marques A; Sousa A
    Respir Res; 2022 Jan; 23(1):16. PubMed ID: 35093093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
    Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
    Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.
    Li W; Wang B; Tan M; Song X; Xie S; Wang C
    Respir Res; 2022 Nov; 23(1):321. PubMed ID: 36403054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
    Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
    PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.